Literature DB >> 7962654

Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A.

T A McCulloch1, S J Harper, P K Donnelly, J Moorhouse, P R Bell, J Walls, J Feehally, P N Furness.   

Abstract

AIMS: To compare the degree of interstitial fibrosis in renal transplant biopsy specimens from immunosuppressed patients using conventional doses of cyclosporin with and without calcium channel blockade with a combination of low dose cyclosporin and azathioprine; to correlate the degree of interstitial fibrosis with the glomerular filtration rate.
METHODS: A single blind histomorphometric assessment was done of cortical interstitial volume fraction from biopsy specimens taken intraoperatively and at one, six, and 12 months after transplantation from three prospectively randomised groups of patients: (A) conventional dose cyclosporin; (B) conventional dose cyclosporin plus nifedipine; (C) low dose cyclosporin plus azathioprine.
RESULTS: Interstitial volume increased with time in all groups. No differences in interstitial volume were present at operation or at one month, but at six months interstitial volume was significantly less in group B than group A (p < 0.001) or group C (p < 0.05). More grafts failed in group A than group B leaving only small numbers for comparison at 12 months. At 12 months the differences persisted but did not reach significance. These results strongly reflected the clinical findings, where glomerular filtration rate was significantly lower in group A than groups B or C at six and 12 months; no differences in glomerular filtration rate were found at one month. In a direct comparison glomerular filtration rate showed a significant negative correlation with interstitial volume fraction.
CONCLUSIONS: These findings suggest that calcium channel blockade with nifedipine slows the development of interstitial fibrosis in renal transplant recipients treated with cyclosporin. When clinical data are considered, it is suggested that calcium channel blockade may have a mitigating effect on the long term nephrotoxic effects of cyclosporin and should be considered as adjunctive treatment in patients requiring this immunosuppressant following renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962654      PMCID: PMC494942          DOI: 10.1136/jcp.47.9.839

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

Review 1.  Calcium and ischemic injury.

Authors:  J Y Cheung; J V Bonventre; C D Malis; A Leaf
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

Review 2.  Cyclosporine nephrotoxicity.

Authors:  B D Myers
Journal:  Kidney Int       Date:  1986-12       Impact factor: 10.612

3.  Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.

Authors:  L Bignardi; G H Neild; R B Hartley; D H Taube; J S Cameron; C J Rudge; D G Williams; C S Ogg
Journal:  Nephrol Dial Transplant       Date:  1987       Impact factor: 5.992

4.  Effect of reduced cyclosporin dosage on long-term renal allograft histology.

Authors:  H E Wilczek; C G Groth; S O Bohman
Journal:  Transpl Int       Date:  1992-05       Impact factor: 3.782

5.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

6.  Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.

Authors:  K Svenson; S O Bohman; R Hällgren
Journal:  Arch Intern Med       Date:  1986-10

7.  Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.

Authors:  G H Neild; D H Taube; R B Hartley; L Bignardi; J S Cameron; D G Williams; C S Ogg; C J Rudge
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

8.  Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.

Authors:  P Ruiz; P C Kolbeck; M W Scroggs; F Sanfilippo
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

9.  Renal histopathologic alterations in patients treated with cyclosporine for uveitis.

Authors:  A G Palestine; H A Austin; J E Balow; T T Antonovych; S G Sabnis; H G Preuss; R B Nussenblatt
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

10.  Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients.

Authors:  S J Harper; J Moorhouse; P S Veitch; T Horsburgh; J Walls; P R Bell; P K Donnelly; J Feehally
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

View more
  3 in total

1.  Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states.

Authors:  P N Furness; L Rogers-Wheatley; K P Harris
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

Review 2.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 3.  Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy.

Authors:  Ekamol Tantisattamo; Ramy M Hanna; Uttam G Reddy; Hirohito Ichii; Donald C Dafoe; Gabriel M Danovitch; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-01       Impact factor: 3.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.